Research and Development
Pfizer says its Sutent meets primary endpoint in Phase III trials for kidney cancer recurrence
July 11, 2016 Research and Development, Sales and Marketing Kidney cancer, Pfizer, Stutent, drug trial
Weekly Movers: Medivation, Bind Therapeutics, Insys…
July 11, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Medivation, XBiotech, juno therapeutics, markets, stocks
Amgen’s Humira biosimilar candidate “highly similar” to originator, says FDA
July 8, 2016 Research and Development, Sales and Marketing ABP-501, AbbVie, Amgen, FDA, Humira, abp 501, biosimilar
US FDA approves Roche Cobas HPV Test
July 8, 2016 Medical Communications, Research and Development HPV, Roche, US FDA, regulation
Eisai criticises NICE and CDF for rare cancer ‘black hole’ in England
July 8, 2016 Medical Communications, Research and Development CDF, Eisai, NICE, black hole
FDA suspends Juno Therapeutics cancer drug trial after patient deaths
July 8, 2016 Medical Communications, Research and Development FDA, juno therapeutics, patient deaths
Lundbeck, Otsuka’s trial Alzheimer’s disease drug gets US FDA fast track designation
July 8, 2016 Medical Communications, Research and Development Alzheimer's disease, Lundbeck, Otsuka, US FDA, drug development, drug trial, fast track designation
Ablynx’s RA therapy matches Roche’s Actemra in Phase IIb trial
July 7, 2016 Medical Communications, Research and Development Ablynx, Actemra, Roche
FDA issues new guidance on next generation sequencing
July 7, 2016 Medical Communications, Research and Development FDA, next generation sequencing, precision medicines initiative
New data shows Sandoz’s Enbrel biosimilar has equivalent efficacy profile
July 7, 2016 Research and Development, Sales and Marketing Amgen, EMA, Enbrel, FDA, Novartis, Sandoz, biosimilars
Biogen and AbbVie’s Zinbryta gets European backing to treat multiple sclerosis
July 7, 2016 Research and Development, Sales and Marketing Biogen, drug approval, european union, multiple sclerosis, zinbryta
Shire gets extended market authorization in Europe for drug to treat children with a rare gastrointestinal condition
July 7, 2016 Research and Development, Sales and Marketing European Commission, Revestive, Shire, market authorisation, short bowel syndrome
Pfizer’s blood cancer drug first to be reappraised from Cancer Drug Fund
July 7, 2016 Research and Development, Sales and Marketing Cancer, Cancer Drugs Fund, NICE, Pfizer, blood cancer, bosulif
Takeda says its cancer drug Adcetris gets European backing in for hodgkin lymphoma
July 6, 2016 Research and Development European Commission, Takeda, drug trial, lymphoma
Merck and Pfizer begin Phase III trials for avelumab in ovarian cancer
July 6, 2016 Research and Development Merck, Pfizer, avelumab
